Darwin Global Management as of Dec. 31, 2021
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 13 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 69.4 | $455M | 7.7M | 59.05 | |
| Intellia Therapeutics (NTLA) | 10.9 | $72M | 606k | 118.24 | |
| Astrazeneca Sponsored Adr (AZN) | 4.6 | $30M | 512k | 58.25 | |
| Inhibrx (INBX) | 3.9 | $26M | 592k | 43.67 | |
| Biontech Se Sponsored Ads (BNTX) | 3.5 | $23M | 90k | 257.80 | |
| Enanta Pharmaceuticals (ENTA) | 1.9 | $12M | 166k | 74.78 | |
| Fate Therapeutics (FATE) | 1.4 | $9.0M | 154k | 58.51 | |
| Keros Therapeutics (KROS) | 1.0 | $6.5M | 112k | 58.51 | |
| Vir Biotechnology (VIR) | 0.9 | $6.1M | 146k | 41.87 | |
| Chemocentryx | 0.9 | $5.9M | 162k | 36.41 | |
| Fulcrum Therapeutics (FULC) | 0.9 | $5.6M | 317k | 17.69 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $3.1M | 216k | 14.54 | |
| Verve Therapeutics (VERV) | 0.1 | $852k | 23k | 36.88 |
